Jon H. Condra

7.1k total citations · 2 hit papers
47 papers, 5.1k citations indexed

About

Jon H. Condra is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Jon H. Condra has authored 47 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Virology, 28 papers in Infectious Diseases and 13 papers in Molecular Biology. Recurrent topics in Jon H. Condra's work include HIV Research and Treatment (31 papers), HIV/AIDS drug development and treatment (27 papers) and HIV/AIDS Research and Interventions (15 papers). Jon H. Condra is often cited by papers focused on HIV Research and Treatment (31 papers), HIV/AIDS drug development and treatment (27 papers) and HIV/AIDS Research and Interventions (15 papers). Jon H. Condra collaborates with scholars based in United States, France and United Kingdom. Jon H. Condra's co-authors include Emilio A. Emini, William A. Schleif, Paul Deutsch, Anne R. Meibohm, Leslie Jonas, Deborah K. McMahon, Jeffrey Chodakewitz, Roy M. Gulick, Joseph J. Eron and Charles J. Gonzalez and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Jon H. Condra

47 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

1997 1.5k citations Roy M. Gulick, John W. Mellors et al. New England Journal of Medicine profile →
In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1995 810 citations Jon H. Condra, William A. Schleif et al. Nature profile →

Peers

Countries citing papers authored by Jon H. Condra

Since Specialization

Citations

This map shows the geographic impact of Jon H. Condra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon H. Condra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon H. Condra more than expected).

Fields of papers citing papers by Jon H. Condra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon H. Condra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon H. Condra. The network helps show where Jon H. Condra may publish in the future.

Co-authorship network of co-authors of Jon H. Condra

This figure shows the co-authorship network connecting the top 25 collaborators of Jon H. Condra. A scholar is included among the top collaborators of Jon H. Condra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon H. Condra. Jon H. Condra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Short Communication: In Vitro Synergy between Peptides or Neutralizing Antibodies Targeting the N- and C-Terminal Heptad Repeats of HIV Type 1 gp41 2008 ·AIDS Research and Human Retroviruses ·Renee Hrin, Donna L. Montgomery, Fubao Wang, Jon H. Condra, Zhiqiang An, William R. Strohl, Elisabetta Bianchi, Antonello Pessi, Joseph G. Joyce, (unknown)	10
2	HIV Type 1 Vaccines for Worldwide Use: Predicting In-Clade and Cross-Clade Breadth of Immune Responses 2007 ·AIDS Research and Human Retroviruses ·Adam C. Finnefrock, (unknown), (unknown), John W. Shiver, Danilo R. Casimiro, Jon H. Condra	11
3	Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys 2004 ·Vaccine ·Fan Jiang, Xiaoping Liang, Melanie Horton, Helen C. Perry, Michael Citron, (unknown), Tong‐Ming Fu, Joseph G. Joyce, Craig T. Przysiecki, Paul M. Keller, Victor M. Garsky, Roxana Ionescu, (unknown), Li Shi, Michael Chastain, Jon H. Condra, Mary-Ellen Davies, Jason J. Z. Liao, Emilio A. Emini, John W. Shiver	275
4	Treatment with Indinavir, Efavirenz, and Adefovir after Failure of Nelfinavir Therapy 2003 ·The Journal of Infectious Diseases ·Alfred J. Saah, David W. Haas, Mark J. DiNubile, Joshua Chen, Daniel Holder, Rand R. Rhodes, (unknown), Kalpana Bakshi, Robert M. Danovich, Donald J. Graham, Jon H. Condra	11
5	Potential New Therapies for the Treatment of HIV-1 Infection 2002 ·Annual Review of Medicine ·Jon H. Condra, Michael D. Miller, Daria J. Hazuda, Emilio A. Emini	27
6	Drug Resistance and Predicted Virologic Responses to Human Immunodeficiency Virus Type 1 Protease Inhibitor Therapy 2000 ·The Journal of Infectious Diseases ·Jon H. Condra, Christos J. Petropoulos, Rainer Ziermann, William A. Schleif, (unknown), Emilio A. Emini	116
7	Baseline Human Immunodeficiency Virus Type 1 Phenotype, Genotype, and RNA Response after Switching from Long‐Term Hard‐Capsule Saquinavir to Indinavir or Soft‐Gel–Capsule Saquinavir in AIDS Clinical Trials Group Protocol 333 2000 ·The Journal of Infectious Diseases ·Michael F. Para, David V. Glidden, Robert W. Coombs, Ann C. Collier, Jon H. Condra, Charles Craig, Roland L. Bassett, Randi Y. Leavitt, Sally Snyder, Vincent McAuliffe, Charles A. Boucher	30
8	Associations between Amino Acids in the Evolution of HIV Type 1 Protease Sequences under Indinavir Therapy 1999 ·AIDS Research and Human Retroviruses ·Andrew Brown, Bette Korber, Jon H. Condra	24
9	Virological and clinical implications of resistance to HIV-1 protease inhibitors 1998 ·Drug Resistance Updates ·Jon H. Condra	23
10	Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy breakdown → 1997 ·New England Journal of Medicine ·Roy M. Gulick, John W. Mellors, Diane V. Havlir, Joseph J. Eron, Charles J. Gonzalez, Deborah K. McMahon, Douglas D. Richman, Fred Valentine, Leslie Jonas, Anne R. Meibohm, Emilio A. Emini, Jeffrey Chodakewitz, Paul Deutsch, Daniel Holder, William A. Schleif, Jon H. Condra	1531
11	In Vivo Selection of HIV-1 Variants with Reduced Susceptibility to the Protease Inhibitor L-735,524 and Related Compounds 1996 ·Advances in experimental medicine and biology ·Emilio A. Emini, William A. Schleif, Paul Deutsch, Jon H. Condra	12
12	In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors breakdown → 1995 ·Nature ·Jon H. Condra, William A. Schleif, (unknown), Lori J. Gabryelski, Donald J. Graham, J C Quintero, (unknown), H.L. Robbins, Elizabeth Röth, (unknown), (unknown), T. Yang, (unknown), Kathleen Squires, Paul Deutsch, Emilio A. Emini	810
13	Purification and Characterization of HIV-1 Reverse Transcriptase Having a 1:1 Ratio of p66 and p51 Subunits 1994 ·Protein Expression and Purification ·Mark W. Stahlhut, (unknown), Jon H. Condra, Jing-Li Fu, L Gotlib, Donald J. Graham, David B. Olsen	9
14	Human Immunodeficiency Virus Type 1 Protease Inhibitors: Evaluation of Resistance Engendered by Amino Acid Substitutions in the Enzyme's Substrate Binding Site 1994 ·Biochemistry ·Vinod Sardana, A J Schlabach, Pia Graham, Bruce L. Bush, Jon H. Condra, J. Chris Culberson, L Gotlib, Donald J. Graham, Nancy E. Kohl	42
15	CLINICAL DEVELOPMENT OF HIV-1 RESISTANCE TO THE VIRAL PROTEASE INHIBITOR L-735, 524 1994 ·AIDS ·Emilio A. Emini, Paul Deutsch, William A. Schleif, Jon H. Condra	1
16	The genetic and functional basis of HIV-1 resistance to nonnucleoside reverse transcriptase inhibitors 1994 ·PubMed ·Emilio A. Emini, V W Byrnes, Jon H. Condra, William A. Schleif, Vinod Sardana	5
17	Inhibition of HIV-1 reverse transcriptase by pyridinone derivatives. Potency, binding characteristics, and effect of template sequence. 1993 ·Journal of Biological Chemistry ·Steve S. Carroll, David B. Olsen, Carl D. Bennett, L Gotlib, Donald J. Graham, Jon H. Condra, Andrew M. Stern, Jules A. Shafer, Lawrence C. Kuo	41
18	Avian cells expressing the murine Mx1 protein are resistant to influenza virus infection 1991 ·Virology ·Ellen A. Garber, Hilary Chute, Jon H. Condra, L Gotlib, Richard J. Colonno, Roy G. Smith	35
19	Bacterial expression of antibody fragments that block human rhinovirus infection of cultured cells. 1990 ·Journal of Biological Chemistry ·Jon H. Condra, Vinod Sardana, Joanne E. Tomassini, A J Schlabach, M E Davies, D W Lineberger, Donald J. Graham, L Gotlib, Richard J. Colonno	43
20	Evidence for the direct involvement of the rhinovirus canyon in receptor binding. 1988 ·Proceedings of the National Academy of Sciences ·Richard J. Colonno, Jon H. Condra, Satoshi Mizutani, P L Callahan, M E Davies, Mark A. Murcko	180

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact